NCT06012383
- Conditions
- Blood Protein Disorders, Cardiovascular Diseases, Hematologic Diseases, +13 more
- Locations
-
Not specified
Clinical trial condition
Lymphoproliferative Disorders
Explore clinical trials studying Lymphoproliferative Disorders. Study availability and eligibility vary by location and protocol.
10,106 public trials
2,040 recruiting studies
Lymphoproliferative Disorders trial results
NCT04187248
- Conditions
- Acute Lymphoblastic Leukemia, Hematologic Diseases, Hemic and Lymphatic Diseases, +9 more
- Locations
-
- Aarhus University Hospital, Department of Pediatrics Skejby Hospital Aarhus, Aarhus N, Denmark
NCT00078949
- Conditions
- Burkitt Lymphoma, DNA Virus Infections, Epstein-Barr Virus Infections, +19 more
- Locations
-
- Rush-Presbyterian-St. Luke's Medical Centre Chicago, Illinois, United States
- Indiana University Medical Center Indianapolis, Indiana, United States
- Hackensack University Medical Center Hackensack, New Jersey, United States
- University of Cincinnati, Barrett Cancer Centre Cincinnati, Ohio, United States
Completed
Zevalin® Followed by Rituxan® Maintenance in Previously Treated Low Grade Non-Hodgkin's Lymphoma
NCT00168727
- Conditions
- Hemic and Lymphatic Diseases, Immune System Diseases, Immunoproliferative Disorders, +7 more
- Locations
-
- Loma Linda University Loma Linda, California, United States
- North County Oncology Oceanside, California, United States
- Medical Specialists of Fairfield Fairfield, Connecticut, United States
- Queens Hospital Honolulu, Hawaii, United States
NCT03260855
- Conditions
- Hemic and Lymphatic Diseases, Immune System Diseases, Immunoproliferative Disorders, +5 more
- Locations
-
- Institut Universitaire du Cancer de Toulouse CHU de Toulouse Toulouse, France
NCT03128164
- Conditions
- Hemic and Lymphatic Diseases, Immune System Diseases, Immunoproliferative Disorders, +6 more
- Locations
-
- TongJi Medical College Huazhong University of Science& Technology Wuhan, Hubei, China
- Sun Yat-sen University cancer center Guangzhou, China
- Fudan University Shanghai Cancer Center Shanghai, China
NCT04196491
- Conditions
- Blood Protein Disorders, Cardiovascular Diseases, Hematologic Diseases, +12 more
- Locations
-
- Local Institution - 119 Phoenix, Arizona, United States
- Local Institution - 110 Los Angeles, California, United States
- Local Institution - 116 San Francisco, California, United States
- Local Institution - 106 Denver, Colorado, United States
NCT02755597
- Conditions
- Blood Protein Disorders, Cardiovascular Diseases, Hematologic Diseases, +13 more
- Locations
-
- Rocky Mountain Regional VA Medical Center/Eastern Colorado Health Care System /ID# 156524 Aurora, Colorado, United States
- Univ of Colorado Cancer Center /ID# 149130 Aurora, Colorado, United States
- Duke Cancer Center /ID# 149099 Durham, North Carolina, United States
- Gabrail Cancer Center Research /ID# 149098 Canton, Ohio, United States
NCT04445701
- Conditions
- Blood Protein Disorders, Cardiovascular Diseases, Hematologic Diseases, +12 more
- Locations
-
- Mayo Clinic Phoenix, Arizona, United States
- Mayo Clinic Jacksonville, Florida, United States
- Emory University Atlanta, Georgia, United States
- Dana-Farber Cancer Institute Boston, Massachusetts, United States
NCT02340780
- Conditions
- Chronic Disease, Chronic Lymphocytic Leukemia, Disease Attributes, +14 more
- Locations
-
- Tom Baker Cancer Centre Calgary, Alberta, Canada
- Cross Cancer Institute Edmonton, Alberta, Canada
- CancerCare Manitoba Winnipeg, Manitoba, Canada
- QEII Health Sciences Centre Halifax, Nova Scotia, Canada